Search

Champions Oncology Inc

Closed

SectorHealthcare

4.98 -1.97

Overview

Share price change

24h

Current

Min

4.98

Max

5.26

Key metrics

By Trading Economics

Income

241K

-426K

Sales

1.4M

15M

P/E

Sector Avg

35.118

56.432

EPS

-0.03

Profit margin

-2.797

Employees

214

EBITDA

79K

-95K

Dividends

By Acuity

Next Earnings

14 gru 2026

Market Stats

By TradingEconomics

Market Cap

-4M

68M

Previous open

6.95

Previous close

4.98

News Sentiment

By Acuity

50%

50%

115 / 339 Ranking in Healthcare

Champions Oncology Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 wrz 2026, 20:02 UTC

Champions Oncology Inc shares fell slightly, continuing a downward trend since Thursday, despite an early recovery during Friday's trading session.

17 wrz 2026, 20:01 UTC

News

Champions Oncology reported record annual revenue of $59.4 million for fiscal 2026, with shares trading higher amid a positive adjusted EBITDA of $1.6 million.

16 wrz 2026, 19:06 UTC

Champions Oncology Inc is trading higher, experiencing significant volatility with a sharp midday rise after an initial dip, contrasting with three prior sessions that closed lower.

15 wrz 2026, 20:03 UTC

News

Champions Oncology reports a net loss of $426,000 and revenue of $15.2 million. Shares are lower amid broader market declines following weak manufacturing data.

11 wrz 2026, 19:56 UTC

News

Champions Oncology reported Q1 fiscal 2027 revenue of $15.2 million. Shares are lower despite improved gross margin and adjusted EBITDA of approximately $700,000.

10 wrz 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, continuing upward momentum after three consecutive sessions of decline. The stock remains above its 20-day moving average.

9 wrz 2026, 20:07 UTC

Champions Oncology Inc shares declined for a fourth straight day, reaching a session low earlier. No specific news was identified to explain the movement.

8 wrz 2026, 20:13 UTC

Champions Oncology Inc shares are lower in after-market hours, continuing a trend of declining performance over the past three sessions.

4 wrz 2026, 19:07 UTC

Champions Oncology Inc is trading lower after reversing early gains, reflecting a decline since Thursday's close amid unchanged unemployment rates and decelerating wage growth.

3 wrz 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, maintaining strong upward momentum since Wednesday's close, despite no specific news to explain the movement.

2 wrz 2026, 20:08 UTC

Champions Oncology Inc shares are higher today, breaking from a recent pattern of daily gains. No specific news was identified to explain the movement.

28 sie 2026, 19:36 UTC

Champions Oncology Inc. shares are trading roughly flat, with no specific news identified. The stock remains near the lower end of its one-month range.

27 sie 2026, 20:03 UTC

Champions Oncology shares are higher Thursday, reflecting a broader market trend amid declining initial jobless claims reported by the Labor Department.

25 sie 2026, 19:16 UTC

Champions Oncology Inc. is trading higher today, despite a flat performance and remaining below its 20-day moving average. No specific news was identified.

24 sie 2026, 20:06 UTC

News

Champions Oncology reports gross revenue of $59.42 million, with shares declining since Friday's close despite an earlier session increase.

21 sie 2026, 20:06 UTC

Champions Oncology Inc shares are lower in Friday's session amid broader market declines, with no specific news identified to explain the volatility.

20 sie 2026, 19:31 UTC

Champions Oncology Inc is higher today, driven by gains in the Life Sciences Tools & Services sub-sector, despite earlier session declines.

19 sie 2026, 20:02 UTC

Champions Oncology Inc shares declined during Wednesday's session, reaching a low in late morning amid no specific news to explain the downturn.

18 sie 2026, 19:41 UTC

Champions Oncology Inc shares are higher today, despite no specific news. Broader market concerns include inflation and rising treasury yields affecting investor sentiment.

17 sie 2026, 19:36 UTC

Champions Oncology Inc's shares are higher during Monday's session, reflecting a modest increase since Friday's close. The stock remains below its 20-day moving average.

14 sie 2026, 20:02 UTC

Champions Oncology is trading lower, reflecting broader market sentiment amid a surprising decline in U.S. retail sales for July.

13 sie 2026, 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

12 sie 2026, 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

11 sie 2026, 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

10 sie 2026, 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

7 sie 2026, 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

6 sie 2026, 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

5 sie 2026, 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

4 sie 2026, 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

3 sie 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

Peer Comparison

Price change

Champions Oncology Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

115 / 339 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.